Beta Bionics, Inc. (BBNX)
15.49
-1.46
(-8.61%)
USD |
NASDAQ |
Nov 05, 16:00
15.31
-0.18
(-1.16%)
After-Hours: 20:00
Beta Bionics SG&A Expense (TTM) : 124.49M for Sept. 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 124.49M |
| June 30, 2026 | 113.50M |
| March 31, 2026 | 102.76M |
| December 31, 2025 | 92.43M |
| September 30, 2025 | 83.00M |
| June 30, 2025 | 73.79M |
| March 31, 2025 | 50.28M |
| Date | Value |
|---|---|
| December 31, 2024 | 30.26M |
| September 30, 2024 | 14.75M |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| PROCEPT BioRobotics Corp. | 193.05M |
| Edwards Lifesciences Corp. | 1.686B |
| Intuitive Surgical, Inc. | 2.552B |
| Stryker Corp. | 9.05B |
| Zimmer Biomet Holdings, Inc. | 2.622B |